43 results
8-K
CYCN
Cyclerion Therapeutics Inc
19 Jul 23
Submission of Matters to a Vote of Security Holders
5:27pm
by the use of forward-looking terminology such as “believes,” “estimates,” “expects,” “may,” “will,” “should,” “could,” “anticipates,” “projects,” “targets
8-K
CYCN
Cyclerion Therapeutics Inc
12 Jul 23
Other Events
12:00am
,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” “positive,” “projects,” “targets,” “optimistic,” aims
DEFM14A
bbmbvgeazaso4 s8ss
20 Jun 23
Proxy related to merger
4:55pm
PREM14A
7pon3kqusx 4qbv100j
9 Jun 23
Preliminary proxy related to merger
5:23pm
DEFA14A
akwzo105
11 May 23
Additional proxy soliciting materials
7:28pm
8-K
nce7ig pjyksy
11 May 23
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
7:26pm
8-K
EX-99.2
2l4745x2 2o8s8be7
28 Jul 22
Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in
9:00am
8-K
EX-99.1
j8cbsds 8hhl
26 Jul 22
Steven E. Hyman, M.D., Appointed to Cyclerion Therapeutics’ Board of Directors
7:00am
8-K
EX-99.2
mwc66mzfi vx6xc1
10 Jun 22
Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in MELAS Patients at UMDF Mitochondrial Medicine 2022 Symposium
7:01am
8-K
EX-99.1
az80nqtviv n99g
30 Sep 21
On a mission to develop treatments that restore cognitive function CORPORATE PRESENTATION
9:01am